novel tbx22 mutations in chinese no-syndromic cleft lip ... · 2 abstract tbx22 is a contribute...
TRANSCRIPT
1
RESEARCH ARTICLE
Novel TBX22 mutations in Chinese no-syndromic Cleft Lip/Palate families
Running title: TBX22 mutations in Chinese CL/P families
Key words: no-syndromic; cleft lip; cleft palate; TBX22; Chinese
Jiewen Dai1, Chen Xu2, Guomin Wang1, Yun Liang1, Teng Wan1, Yong Zhang1,
Xiaofeng Xu1, Lebin Yu2, Zonggang Che2, Qiqing Han2, Dandan Wu1*, Yusheng
Yang1*
Jiewen Dai and Chen Xu are co-first authors.
1Department of Oral & Cranio-maxillofacial Surgery, Shanghai ninth People’s
Hospital, Shanghai JiaoTong University, School of Medicine, Shanghai, 200011,P.R.
China
2Department of Oral and Maxillofacial Surgery, Central Hospital of ZiBo, Shandong
Zibo 255036, P.R. China
*Co-corresponding authors. Yusheng Yang & Dandan Wu. Department of Oral &
Cranio-maxillofacial Surgery, Shanghai ninth People’s Hospital, Shanghai JiaoTong
University, School of Medicine, NO. 639 Zhizaoju Road, Shanghai, 200011, P.R.
China. E-Mail: [email protected] (Y.S.Y). [email protected] (D.D.W)
2
Abstract
TBX22 is a contribute gene of Cleft Lip/Palate, and many mutations have been
reported. However, the exact role of TBX22 mutation in Chinee no-syndromic Cleft
Lip/Palate (NSCL/P) family has not been clearly explored. In this study, we tried to
investigate the profiles and effects of TBX22 mutation in Chinese NSCL/P family.
Members in two Chinese NSCL/P families, and 200 normal controls were enrolled in
this study. Then DNA sequence and bioinformatic analysis for TBX22 were performed.
The results showed that a novel and essential splicing site mutation, IVS6-1G>C, was
detected in a family with cleft palate. The bioinformatic analysis results showed that
this mutation would lead to abnormal transcription or translation, followed by leading
to a loss of function of TBX22. In addition, A hemizygous missense mutation,
c.874G>A (p.D292N), was firstly showed in another Chinese family, which may
exhibit aggravated effects on the phenotypes of CL/P. Taking these findings together,
this study provided a profile of TBX22 mutation in Chinese NSCL/P families, and
further confirmed the important role of TBX22 in familial cases with X-linked cleft
palate.
3
Introduction
Orofacial clefts, including cleft lip/palate (CL/P) are common congenital birth
defects in human, and the reported prevalence is about 1/700 to 1/2000 for live births
in worldwide (Murray 2002), as well as about 1.64‰ in China. The etiology of
orofacial clefts is greatly unclear, and a generally accepted consensus is multiple
factors, including genetic and environmental factors, contribute to orofacial clefts
(Wu et al. 2012). Many efforts have been carried out to identify these genetic
determinants of orofacial clefts in different regions and different populations, and a
number of genes, such as IRF6, p63, PVRL1, MSX1 and TBX22, have been reported to
be related to syndromic or Mendelian clefts (Dai et al. 2014; Dai et al. 2015). TBX22,
a transcription factor of T-box gene family that shares a highly conserved
DNA-binding domain which encodes 180 amino acids, mainly expressed in palatal
shelves and the base of tongue during craniofacial development (Braybrook et al.
2001). Previous genetic models also showed that TBX22 played crucial role in
palatogenesis and glossogenesis (Haenig et al. 2002; Pauws et al. 2009; Fuchs et al.
2010).
X-linked cleft palate (CPX) is a semidominant disorder characterized by a strong
X linked Mendelian inheritance, and an isolated cleft of the secondary palate,
sometimes accompanied with ankyloglossia (tongue-tie). Its phenotypes exhibit great
varies from a highly arched palate to a complete cleft of the secondary palate.
Previously, several CPX families were described in different populations (Bjornsson
et al. 1989; Gorski et al. 1992), and showed that CPX was caused by mutations in
TBX22 (Braybrook et al. 2001). Many mutations of TBX22 have been reported,
including nonsense, frame-shift, splice-site, or missense mutation (Pauws et al. 2013).
4
Except for familial cases with well-defined CPX, TBX22 mutations also have been
found in many sporadic on-syndromic cleft palate cases (Marcano et al. 2004;
Suphapeetiporn et al. 2007), as well as cleft lip with palate, hypodontia and limb
anomaly (Kantaputra et al. 2011; Kaewkhampa et al. 2012). All these findings
inspired us to investigate the possible roles of TBX22 in Chinese NSCL/P families.
In this study, we sequenced TBX22 in members from two Chinese NSCL/P
families and 200 normal controls, and bioinformatic analysis for TBX22 mutation was
performed to explore the profiles and effects of TBX22 mutation in Chinese NSCL/P
family.
Materials and methods
Patients
The protocols were approved by the Ethics Committee of Shanghai Ninth People’s
Hospital, Shanghai Jiaotong University School of Medicine, and written informed
consents were obtained from all patients or their parents. Members in two Chinese
NSCL/P families and 200 controls were included in this study, and the blood samples
were collected from them.
Family one (Fig. 1A) with CPX characteristics and features was included to
analyze TBX22 mutations. The female proband was presented with isolated cleft
palate (CPI). Her father and two uncles also had CPI. Her family was Han Chinese
origin, and also included another two affected males and two affected females.
Inconsistent with previously reported classic CPX families, family history taking or
inspection excluded ankyloglossia in all these affected members, as well as female
carriers.
Family two, the male proband was presented with cleft lip, cleft palate and cleft
5
alveolar, and his father exhibited cleft lip and slight cleft alveolar, whereas his mother
exhibited no CL/P and cleft alveolar phenotypes.
200 control samples were peoples who admitted to our hospital due to trauma
and had no orofacial clefts or others congenital diseases, and had no history of oral
clefts in their family members.
Sequence and mutation analysis
Genomic DNA was extracted from blood samples according to the standard
protocols. Primer 3 (version 0.4.0, http://frodo.wi.mit.edu/) was used for primer
design. The polymerase chain reaction (PCR) was conducted in a 10L reaction
system. PCR products were purified with ExoSAP-IT (USP Corp., Cleveland, OH)
and sequenced using BigDye terminator chemistry and ABI 3700 DNA sequencer
according to the standard procedure. The results were analyzed using Sequenche
(version 4.2; Gene Codes Corp., Ann Arbor, MI), and were compared to the
corresponding normal mRNA (NCBI Reference Sequence: NM_001109878.1), cDNA
and genomic DNA sequences. For variation sites, 200 controls from unaffected
ethnic-matched people were screened.
Putative missense mutations were analyzed in silico by 3 Web-based programs:
PANTHER (http://www.pantherdb.org/), PolyPhen
(http://genetics.bwh.harvard.edu/pph/) and SIFT (http://sift.jcvi.org/). Augustus
(http://bioinf.uni-greifswald.de/augustus/submission) and Netgene2
(http://www.cbs.dtu.dk/services/NetGene2/) were used to predict the effect of splicing
site mutations. Phyer2 was used to predict the 3D structure of TBX22 protein (Kelley
et al. 2015).
Protein sequence comparison
Protein sequence alignments were completed by BioEdit Sequence Alignment
6
Editor. The complete TBX22 protein sequences and corresponding proteins were first
downloaded from the Ensembl genome browser (http://asia.ensembl.org/) and saved
as FASTA format. Then protein sequence was imported into the BioEdit Sequence
Alignment Editor software. The human TBX22 protein sequence was aligned with
mouse, rat, monkey and rabbit TBX22 protein sequence, as well as human TBX1,
TBX4, TBX15 and TBX21 protein sequence using the function of ClustalW Multiple
alignment.
Results
IVS6-1G>C mutation in family one
An IVS6-1G>C transversion mutation was detected (Fig. 1B) in family one. The
proband was marked with an arrow in Fig. 1A. The same mutation also was found in
female carriers, as well as the affected people in this family, but absent in the
unaffected members. Although the typical CPX and ankyloglossia were not observed
based on examination and family history, a semi-dominant X linked inheritance was
clearly established. To our knowledge, this was the first CPX family reported in
Chinese population about the splicing site mutation in TBX22 according to Human
Gene Mutation Database. This mutation was absent in all the 200 controls.
The possible effect of this splicing site mutation was predicted by Augustus and
Netgene2, and the Augustus analysis results showed that the stop codon appeared in
advance, and only 5 CDS sequence were obtained (Fig.2A). The Netgene2 analysis
results showed that the normal splicing site “tccatagattac” disappeared when the
mutation existed (Fig.2B). Only 265 amino acids would be obtained based on the
7
translation from the residue 5 CDS sequence (Fig.2C), whereas there were 520 amino
acids in normal human TBX22 protein, and the structures of the mutant TBX22
protein also were disturbed when compared with normal protein (Fig.3). These
findings implied that IVS6-1G>C transversion mutation may lead to a loss of function
of TBX22 protein.
c.874G>A mutation in family two
A single base substitution (c.874G>A; p.D292N) was identified in exon 7 in
family two (Fig. 4A, B). The proband was a boy with unilateral complete cleft lip and
palate. The unaffected mother carried the same mutation. His father exhibited
unilateral cleft lip and alveolar, but did not carry this mutation. This change was not
found in 200 controls and was not present in the SNP database or 1000 Genomes
database, which also was firstly reported in Chinese population. This mutation located
outside the T-box domain, resulting in a substitution of aspartic acid residue to
asparagine residue (p.D292N). Aspartic acid residue at the position 292 of the
polypeptide was conserved across species, while not conserved in the TBX1, TBX4,
TBX15 and TBX21 subfamily of T-Box protein (Fig. 4C). The SIFT analysis score was
0.15, meaning the change might be tolerated. PANTHER and Polyphen predicted this
variation may be harmful. The 3D structure predicted by Phyer2 software showed that
this mutation would modify the secondary structures of TBX22 protein, and a new
alpha helix followed the T-Box region was observed (Fig.5).
Discussion
The important role of TBX22 in the development of cleft palate has been greatly
confirmed in recent researches. Previous study showed that up to 4% of unselected
8
cleft palate cases have TBX22 mutations (Marcano et al. 2004). A study in the Thai
population identified four potentially pathogenic mutations in 53 non-syndromic cleft
palate cases (Suphapeetiporn et al. 2007). Unlike these positive reports, no new
mutation was detected in sporadic CPI patients in china. This heterogeneity may be
explained by the difference of ethnic or geographical origin.
A Chinese family with X-linked CP was reported in this study. The IVS6-1G>C
mutation happened in the essential splicing junction that should be strictly conserved
according to the “GT-AG rule”, and leaded to the missing of one transcription
acceptor, followed by disturbing the cut off of intron 5, which may disturb the
function of TBX22 through three most possible mechanisms: a premature transcription
termination, an exon skipping or an intron retention. All of these changes would result
in truncated or unstable TBX22 mRNA, and nonsense-mediated decay may occur to
avoid producing an aberrant protein by removing the entire transcript. Braybrook et al
reported an IVS6+1 mutation in an Icelandic family (Braybrook et al. 2002), and did
not detect any PCR product across the mutation site, as well as other portions of the
transcript, which supported the theory of nonsense-mediated decay. In addition, even
a truncated protein was obtained from the truncated mRNA, the structure and function
of the protein may be disturbed, which was confirmed in this study by our prediction
of protein structure, and may affect DNA binding, sumoylation or transcriptional
repression that were reported in previous studies (Andreou et al. 2007; Fu et al.
2015).
This reported Chinese CPX family exhibited two features. One feature was
although the pedigree size and family genogram implied X-linked inheritance, the
typical incidental symptom, ankyloglossia (Kantaputra et al. 2011), was not found in
any affected, unaffected or carried family members. Previous researchers analyzed
9
CPX families and concluded that ankyloglossia was a common phenotype associated
with TBX22 mutations (Marcano et al. 2004), but its occurrence was not a prerequisite
for cleft palate. In addition, the cleft palate and ankyloglossia were independent
effects of loss of TBX22 function. A previous study on Finnish population also
showed that mutations in TBX22 was not a major cause of ankyloglossia (Klockars et
al. 2012). All of these findings implied that semidominant tendency characterized by a
strong X-linked Mendelian inheritance of cleft palate, with or without ankyloglossia,
may be an indicator for a diagnosis of CPX. The other feature was the diversity of
phenotypes of the heterozygous females in this family. Females who harbor this
mutation have either cleft soft palate or exhibited no defect. A possible mechanism
may due to the non-random X inactivation.
In family two, a boy with cleft lip and palate had an inherited mutation of
c.874G>A (p.D292N), and was obtained from his healthy mother. His father had cleft
lip and cleft alveolar, but did not carry the mutated TBX22. The position of mutation
located outside the T-box domain, and resulted in substitution of an aspartic acid
residue by an asparagine residue. The mutation altered the charge of TBX22 protein,
but did not alter the chemical polarity of the amino acid, and the silico prediction
results showed low scores and a weak functional impact. However, 3D structure
predicted by Phyer2 software showed that the mutation would modify the secondary
structures of TBX22 protein. Unlike the T-box domain, little was known about the
effect of C-terminal domain where possible functional domain may exist. In addition,
whether the change of charge would influence the transcription regulation and
protein-protein interaction also needed to be further investigated. Although given the
phenotypes of the proband and his father, we can not exclude the involvement of
others autosomal gene that results in the cleft phenotypes, this mutation of TBX22
10
may aggravate the phenotypes of the proband when compared to his father, and the
cleft lip and cleft alveolar may be caused by others mutant gene that obtained from his
father, whereas cleft palate was caused by mutation of TBX22 that obtained from his
mother. Of course, the mechanism need to be further investigated in future. A similar
phenomenon also had been reported in a previous study (Kaewkhampa et al. 2012).
In summary, this study reported a novel and essential splicing site mutation,
IVS6-1G>C, in a family with cleft palate, which would lead to abnormal transcription
or translation, followed by resulting in a loss of function of TBX22 protein. In
addition, a hemizygous missense mutation, c.874G>A (p.D292N), was firstly showed
in another Chinese family, which may exhibit aggravated effects on the phenotype of
CL/P. All of these findings provided a profile of TBX22 mutation in Chinese NSCL/P
families, and further confirmed the important role of TBX22 in familial cases with
X-linked cleft palate. Functional study and screening in larger sample sizes are
recommended to enrich the molecular mechanisms of TBX22 that contribute to CL/P.
Acknowledgments
We thanks the patients and their families for participating in our study, and being
gracious with their time and effort. We also thank the research teams of Birth Defect
Research Center & Pathology Research Center, Fudan University, Shanghai, China,
who helped with this research.
The study is supported by Interdisciplinary Program of Shanghai Jiaotong University
(Nos.YG2016MS08, YG2016QN11), National key research and development
program (No. 2016YFC1000502), National Natural Science Foundation of China (No.
11
81300842).
Conflict of interest
The authors declare no competing financial interests.
References
Andreou A.M., Pauws E., Jones M.C., Singh M.K., Bussen M., Doudney K., et al.
2007 TBX22 missense mutations found in patients with X-linked cleft palate
affect DNA binding, sumoylation, and transcriptional repression. Am J Hum
Genet. 81, 700-12.
Bjornsson A., Arnason A. and Tippet P. 1989 X-linked cleft palate and ankyloglossia
in an Icelandic family. Cleft Palate J. 26, 3-8.
Braybrook C., Doudney K., Marcano A.C., Arnason A., Bjornsson A., Patton M.A., et
al. 2001 The T-box transcription factor gene TBX22 is mutated in X-linked
cleft palate and ankyloglossia. Nat Genet. 29, 179-83.
Braybrook C., Lisgo S., Doudney K., Henderson D., Marcano A.C., Strachan T., et al.
2002 Craniofacial expression of human and murine TBX22 correlates with the
cleft palate and ankyloglossia phenotype observed in CPX patients. Hum Mol
Genet. 11, 2793-804.
Dai J., Mou Z., Shen S., Dong Y., Yang T. and Shen S.G. 2014 Bioinformatic analysis
of Msx1 and Msx2 involved in craniofacial development. J Craniofac Surg.
25, 129-34.
Dai J., Yu H., Si J., Fang B. and Shen S.G. 2015 Irf6-Related Gene Regulatory
Network Involved in Palate and Lip Development. J Craniofac Surg. 26,
1600-5.
Fu X., Cheng Y., Yuan J., Huang C., Cheng H. and Zhou R. 2015 Loss-of-function
mutation in the X-linked TBX22 promoter disrupts an ETS-1 binding site and
leads to cleft palate. Hum Genet. 134, 147-58.
Fuchs A., Inthal A., Herrmann D., Cheng S., Nakatomi M., Peters H. et al. 2010
Regulation of TBX22 during facial and palatal development. Dev Dyn. 239,
2860-74.
Gorski S.M., Adams K.J., Birch P.H., Friedman J.M. and Goodfellow P.J. 1992 The
gene responsible for X-linked cleft palate (CPX) in a British Columbia native
kindred is localized between PGK1 and DXYS1. Am J Hum Genet. 50,
1129-36.
Haenig B., Schmidt C., Kraus F., Pfordt M. and Kispert A. 2002 Cloning and
expression analysis of the chick ortholog of TBX22, the gene mutated in
X-linked cleft palate and ankyloglossia. Mech Dev.117, 321-5.
Kaewkhampa A., Jotikasthira D., Malaivijitnond S. and Kantaputra P. 2012 TBX22
12
mutation associated with cleft lip/palate, hypodontia, and limb anomaly. Cleft
Palate Craniofac J. 49, 240-4.
Kantaputra P.N., Paramee M., Kaewkhampa A., Hoshino A., Lees M., McEntagart M.,
et al. 2011 Cleft lip with cleft palate, ankyloglossia, and hypodontia are
associated with TBX22 mutations. J Dent Res. 90, 450-5.
Kelley L.A., Mezulis S., Yates C.M., Wass M.N. and Sternberg M.J. 2015 The Phyre2
web portal for protein modeling, prediction and analysis. Nat Protoc. 10,
845-58.
Klockars T., Kyttanen S. and Ellonen P. 2012 TBX22 and tongue-tie. Cleft Palate
Craniofac J. 49, 378-9.
Marcano A.C., Doudney K., Braybrook C., Squires R., Patton M.A., Lees M.M., et al.
2004 TBX22 mutations are a frequent cause of cleft palate. J Med Genet. 41,
68-74.
Murray J.C. 2002 Gene/environment causes of cleft lip and/or palate. Clin Genet. 61,
248-56.
Pauws E., Hoshino A., Bentley L., Prajapati S., Keller C., Hammond P., et al. 2009
TBX22null mice have a submucous cleft palate due to reduced palatal bone
formation and also display ankyloglossia and choanal atresia phenotypes. Hum
Mol Genet. 18, 4171-9.
Pauws E., Peskett E., Boissin C., Hoshino A., Mengrelis K., Carta E., et al. 2013
X-linked CHARGE-like Abruzzo-Erickson syndrome and classic cleft palate
with ankyloglossia result from TBX22 splicing mutations. Clin Genet. 83,
352-8.
Suphapeetiporn K., Tongkobpetch S., Siriwan P. and Shotelersuk V. 2007 TBX22
mutations are a frequent cause of non-syndromic cleft palate in the Thai
population. Clin Genet. 72, 478-83.
Wu T., Fallin M.D., Shi M., Ruczinski I., Liang K.Y., Hetmanski J.B., et al. 2012
Evidence of gene-environment interaction for the RUNX2 gene and
environmental tobacco smoke in controlling the risk of cleft lip with/without
cleft palate. Birth Defects Res A Clin Mol Teratol. 94, 76-83.
13
Figure legends
Figure.1. Pedigree and gene sequencing results of members in family one. (A) Three
generation members in a Chinese family with cleft palate. Filled symbols indicate a
cleft palate phenotype; circles with dots indicate obligate female carriers. (B)The
sequence traces showed the IVS6-1G>C mutation in affected male, as well as carried
and affected female.
Figure.2. Analysis of IVS6-1G>C mutation of TBX22 using Augustus and Netgene2
software. (A) Sequence analysis of normal TBX22 (above the black line) and TBX22
IVS6-1G>C mutant (under the black line) by Augustus software showed that normal
TBX22 mRNA had 8 CDS and 7 introns which was similar with the actual situation,
whereas TBX22 with IVS6-1G>C mutation had only 5 exons, and the stop codon
appeared in advance. (B) Netgene2 analysis showed that the normal splicing site
14
“tccatagattac” was recognized as a transcription acceptor (number 13100, red
straight line), whereas the acceptor disappeared (dotted line) when the IVS6-1G>C
mutation existed. (C) 265 amino acids were obtained based on the translation from the
residue 5 CDS sequence using the translate tool in ExPASy on-line software.
Figure.3. The 3D structure of normal and IVS6-1G>C mutant TBX22 protein that
predicted by Phyer2 software.
15
Figure.4. Information and sequencing results of TBX22 in family two. (A) The
proband exhibited cleft lip and palate, and father exhibited cleft lip and cleft alveolar
but without cleft palate, whereas his mother exhibited no CL/P phenotypes. A
mutation of c.874G>A (p.D292N) was detected in the proband and his mother, but did
not be detected in his father. (B) Sequence traces showed the proband (hemizygote)
and his mother (heterozygote) have c.874G>A (p.D292N) variant. (C) Aspartic acid
residue at the position 292 of TBX22 protein chain is conserved across species, while
not conserved in the TBX1, TBX4, TBX15 and TBX21 subfamily of T-Box protein.
16
Figure.5. The 3D structure of normal and c.874G>A (p.D292N) mutant TBX22
protein that predicted by Phyer2 software. (A) The 3D structure of TBX22 protein
showed that the mutation of c.874G>A (p.D292N) would not obviously disturb the
T-Box domain (rectangle region), but would lead to appearance of a new alpha helix
followed the T-Box region (arrow head). (B) Analysis of the secondary structure of
TBX22 protein also showed appearance of a new alpha helix around the position 292.
17